Clinical Trial Update: Sitravatinib and Tislelizumab in Patients With Metastatic Uveal Melanoma With Liver Metastases. [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating sitravatinib in combination with tislelizumab for metastatic uveal melanoma with liver metastases has completed; the update does not in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Uveal Melanoma

Drugs mentioned

• Sitravatinib (sitravatinib)
• Tislelizumab (tislelizumab)

Snippet

Sponsor: Grupo Español Multidisciplinar de Melanoma | Conditions: Uveal Melanoma | Phase 2 | Status: COMPLETED